Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

ShangPharma Corp (SHP) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/15/2017 BW Xenetic Biosciences Reports 2017 Third Quarter Financial Results and Provides Corporate Update
05/16/2017 BW Xenetic Biosciences Reports 2017 First Quarter Financial Results and Provides Business Update
04/03/2017 BW Xenetic Biosciences Reports 2016 Year End Financial Results and Provides Business Update
03/09/2017 BW Xenetic Biosciences to Present at the 29th Annual ROTH Conference
04/15/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
04/02/2013 SC 13D/A Hui Michael Xin reports a 0% stake in ShangPharma Corporation
04/02/2013 SC 13D/A TPG Group Holdings Advisors, Inc. reports a 0% stake in ShangPharma Corporation
04/02/2013 SC 13D/A ShangPharma Holdings Ltd reports a 0% stake in ShangPharma Corporation
03/28/2013 SC 13E3/A Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
03/28/2013 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
03/20/2013 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
02/27/2013 SC 13D/A Hui Michael Xin reports a 66.7% stake in ShangPharma Corporation
02/26/2013 SC 13D/A ShangPharma Holdings Ltd reports a 66.7% stake in ShangPharma Corporation
02/26/2013 SC 13D/A ShangPharma Corp reports a 66.7% stake in ShangPharma Corporation
02/25/2013 SC 13E3/A Form SC 13E3 - Going private transaction by certain issuers [amend]
02/25/2013 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
12/26/2012 SC 13D ShangPharma Holdings Ltd reports a 66.9% stake in ShangPharma Corporation
12/26/2012 SC 13D/A ShangPharma Corp reports a 66.9% stake in ShangPharma Corporation
12/26/2012 SC 13D/A Hui Michael Xin reports a 66.9% stake in ShangPharma Corporation
12/26/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
11/23/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
11/13/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
08/27/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
08/20/2012 PRN ShangPharma Announces Second Quarter 2012 Results
08/06/2012 PRN ShangPharma to Report Second Quarter 2012 Financial Results on August 20, 2012
08/03/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
08/03/2012 PRN ShangPharma Independent Committee Appoints Financial Advisor
07/06/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
06/04/2012 PRN ShangPharma and Lilly Celebrate 10 Years of Partnership
05/21/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
05/04/2012 20-F/A Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
05/02/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
04/30/2012 20-F Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
03/13/2012 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy